Nov 14, 2022 / 04:00PM GMT
Operator
Okay. Our usual standard disclaimer. And the agenda today. So first, I will give a little bit of an introduction, and then Carl will do an update on our commercial execution at around noon or actually at noon, EDA will start hosting a few fireside chats. So here, we tried to pull together, true thought leaders that represents our industry in the best possible way.
So we have Claudia, who is an epidemiologist, doing a lot of pop health studies; and (inaudible) from Pfizer, Charlotte Teunissen, a thought leader in neuroscience. Laurie Turner representing a (inaudible) and then the grandfather or father of Proteomics (inaudible). Then either we'll blow you away and sharing all link insight, something we are extremely proud of. And then I'll do a little bit of wrap up, and then we have a Q&A session to end the day.
So what we're hoping that you will take away from today is as an organization, you're never more valuable than the return on investment or the value that you create for your customers. So I think what we've been extremely successful with and unique with our disruptive
Olink Holding AB (publ) Investor Day Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
